Tanja Lund Erichsen

Tanja Lund Erichsen is an experienced leader in the pharmaceutical industry, currently serving as Senior Director of Alliance Management for Rare Diseases at Zealand Pharma since August 2022. Prior to this role, Tanja held several key positions, including Head of National Pharmacovigilance at the Danish Medicines Agency from March 2017 to August 2022 and Interim Divisional Director of Pharmacovigilance during 2020-2021. Tanja's extensive experience includes work as Associate Director at Novo Nordisk, where responsibilities encompassed overseeing trial supply delivery for late-phase clinical trials, and as Project Manager and Head of Global Clinical Operations Neurology at H Lundbeck A/S. Tanja's academic background includes a Postgraduate Master in Industrial Drug Development and an MSc in In vitro Pharmacology, both from the University of Copenhagen.